Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma

Authors:

Abstract
Background: Intrahepatic cholangiocarcinoma (iCC) is a rare malignant liver tumor with limited therapeutic advancements. Despite its increasing global incidence knowledge of treatment options remains stagnant, leading to poor five-year patient survival rates and high recurrence post-surgery. ALDH1A1, a member of the ALDH superfamily, is associated with cancer stem cells and has conflicting reports regarding its prognostic role in iCC.

This publication has 58 references indexed in Scilit: